Nucleocapsid protein (N protein) (N protein)

The Nucleocapsid (N) protein is a primary structural component of coronaviruses, such as SARS-CoV-2, responsible for packaging the viral RNA genome into a ribonucleoprotein complex (UniProt P0DTC9). It plays a critical role in viral assembly, replication, and the modulation of host cell immune responses (PubMed: 32733533). In vaccine research, Nucleocapsid protein epitopes on VLP refers to the presentation of conserved N protein segments on Virus-Like Particles to enhance immunogenicity and induce robust T-cell responses (PubMed: 33053431). Unlike the rapidly mutating Spike protein, the N protein is highly conserved, making it an ideal target for broad-spectrum vaccines and diagnostic assays (NIH: Gene 43740575). Therapeutic approaches utilizing these epitopes aim to provide cross-reactive immunity against multiple viral variants by leveraging the high density and repetitive structure of VLPs to stimulate the immune system. This strategy is particularly relevant for developing next-generation vaccines that can provide protection even when surface proteins undergo significant antigenic drift. Additionally, small molecule inhibitors targeting the N protein RNA-binding domain are being explored as potential antiviral treatments to disrupt the viral life cycle.

Other names

NucleoproteinNC proteinN-proteinViral nucleocapsid proteinNucleocapsid protein epitopes on VLP

Induction of cellular and humoral immunity against conserved viral antigens or direct inhibition of viral ribonucleoprotein complex formation.